Diamyd Medical AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 1994-01-01
- Employees
- 25
- Market Cap
- -
- Website
- http://www.diamyd.com
Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals At Risk for Type 1 Diabetes
Phase 2
Recruiting
- Conditions
- Diabetes Mellitus, Type 1PreventionAutoimmune Diseases
- Interventions
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Diamyd Medical AB
- Target Recruit Count
- 16
- Registration Number
- NCT05683990
- Locations
- 🇸🇪
Lund University/CRC, Skåne University Hospital,, Malmö, Sweden
A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
Phase 3
Recruiting
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®Dietary Supplement: Colecalciferol 2000 IUBiological: Placebo
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Diamyd Medical AB
- Target Recruit Count
- 330
- Registration Number
- NCT05018585
- Locations
- 🇵🇱
Kliniczny Szpital Wojewódzki nr 2 im. Św. Jadwigi Królowej w Rzeszowie, II Klinika Pediatrii, Endokrynologii i Diabetologii Dziecięcej, Rzeszów, Poland
🇵🇱Instytut Diabetologii Sp. z o.o, Warsaw, Poland
🇵🇱Panstwowy Instytut Medyczny MSWiA Klinika Chorob Wewnetrznych, Endokrynologii i Diabetologii, Warsaw, Poland
Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes
Phase 2
Completed
- Conditions
- Metabolic DiseaseInsulin Dependent DiabetesDiabetes MellitusEndocrine System DiseasesJuvenile DiabetesAutoimmune DiabetesVitamin DPhysiological Effects of DrugsAutoimmune DiseasesDiabetes Mellitus, Type 1
- Interventions
- Biological: DiamydBiological: Placebo for DiamydDietary Supplement: Placebo for Vitamin DDietary Supplement: Vitamin D
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Diamyd Medical AB
- Target Recruit Count
- 109
- Registration Number
- NCT03345004
- Locations
- 🇪🇸
Pediatrics Endocrinology and Diabetology, Hospital Vall D'Hebrón, Barcelona, Spain
🇪🇸Adult Endocrinology and Diabetology, Hospital Carlos Haya, Málaga, Spain
🇪🇸Adult and Pediatrics Endocrinology and Diabetology, Hospital Universitario Cruces, Barakaldo, Spain
© Copyright 2025. All Rights Reserved by MedPath